Evidence map›Paper›PMID 37640833›Full record

ArticleInflammation2024

Effects of Inhibition of IKK Kinase Phosphorylation On the Cellular Defence System and HSP90 Activity.

Miriam Giacomarra, Martina La Torre, Giovanna Montana

Open access · hybridAbstract read
In one paragraph

Article in Inflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Miriam Giacomarra *Istituto di Ricerca e Innovazione Biomedica, Consiglio Nazionale delle Ricerche (CNR), Via Ugo La Malfa 153, 90146, Palermo, Italy.ORCID http://orcid.org/0000-0003-2721-4458
Martina La Torre *Consiglio Nazionale delle Ricerche (CNR), Istituto di Farmacologia Traslazionale, 00133, Rome, Italy.
Giovanna MontanaConsiglio Nazionale delle Ricerche (CNR), Istituto di Farmacologia Traslazionale, 00133, Rome, Italy. Giovanna.montana@ift.cnr.it.ORCID http://orcid.org/0000-0003-3368-4114
Istituto di Farmacologia Traslazionale · ITInstitute for Biomedical Research and Innovation · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was conceived to examine the effects of inhibition of BMS-345541 mediated IKK kinase phosphorylation on the cellular defence system as well as on anti-inflammatory response and HSP90 activity. The analysis was conducted in A549 cell line, since such cells carry a homozygous Keap1 mutation (G333C) that alters its interaction with Nrf2. Recent data have highlighted that Keap1, HSP90 protein and IKK kinase interact reciprocally and particularly Keap1 protein is involved in HSP90 and anti-oxidative pathway regulation. The activities of COX2 and HO1 were investigated by real time and immunoblot analysis along with the synthesis and activity of inducible forms of heat shock protein HSP90. Pre-treatment with IKK kinase inhibitor proved to be a protective means to lower the activity of inflammatory cascade, so preventing the formation of excessive amounts of pro-inflammatory molecules. The inhibitor of IKK kinase BMS-345541 was added to cultured A549 cells before the Escherichia coli lipopolysaccharide (LPS) addition. The viability of the cells was determined after 1-24 h incubation with BMS-345541 at concentrations ranging from 1,25-5 µM. It was found that 1 µM concentration does not significantly affected cell viability (data not shown). As a result, the treatment with 1 μM of BMS-345541 induces the inhibition of IKK phosphorylation. In the A549 cells treated with BMS-345541 and LPS, COX2 activity is not induced: mRNA and protein levels have not increased, while there is an increase in the level of HSP90, HO1 proteins and mRNA. The results suggest that the IKK inhibition is effective in the reduction of the inflammatory response thanks to mechanisms involving both the heat shock cellular defense system and the antioxidative pathway.

Indexed as

I-kappa B KinaseNF-kappa BCyclooxygenase 2HSP90 Heat-Shock ProteinsKelch-Like ECH-Associated Protein 1LipopolysaccharidesNF-E2-Related Factor 2PhosphorylationRNA, MessengerCyclooxygenase 2HSP90 Heat-Shock ProteinsI-kappa B KinaseKelch-Like ECH-Associated Protein 1LipopolysaccharidesNF-E2-Related Factor 2NF-kappa BRNA, Messengeranti-oxidative pathwayHSP90IKK kinaseinflammationKeap1

Identifiers

PMID37640833
PMCPMC10799094
OpenAlexW4386208492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.